India-made iNCOVACC, world's first intra-nasal vaccine to receive approval for both primary series, Heterologous booster
INCOVACC, on Tuesday, became the world's first intra-nasal vaccine to receive both Primary series and Heterologous booster approval, Bharat Biotech International Limited (BBIL) announced in a press release.